Concepedia

Publication | Closed Access

Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial

DOI

87

Citations

0

References

2017

Year

Ezra E.W. Cohen, Kevin J. Harrington, Christophe Le Tourneau, José Dinis, Lisa Licitra, M-J. Ahn, Ainara Soria, J-P. Machiels, Nicolas Mach, Ranee Mehra,
Annals of Oncology

No additional data available for this publication yet. Check back later!